Utah Medical Products Inc Dossier
Qualitative Analysis
Business overview
Utah Medical Products, Inc. (UTMD) is a specialty medical device company that designs, develops, manufactures, and markets a broad range of proprietary, disposable, and reusable medical devices. Founded in 1978 and headquartered in Midvale, Utah, the company focuses on healthcare sectors including obstetrics, gynecology, neonatal intensive care, urology, electrosurgery, and critical care. UTMD's product portfolio features specialized offerings such as the Filshie Clip System for permanent female contraception (which represented 26% of total sales in 2025), the Deltran disposable pressure transducer line, and neonatal blood microsampling devices like the ABC TinyDraw. The company operates manufacturing and distribution facilities in the United States, Ireland, the United Kingdom, and Australia, serving clinical end-users directly and through a global network of independent distributors.
Research as of 20 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
Transitioning the manufacturing of Filshie Clips from a UK third-party subcontract manufacturer to UTMD's owned facility in Ireland. This transition has involved significant investment in new equipment, operator training, and securing international regulatory approvals.
Expected impact: Expected to lower manufacturing costs, improve supply chain control, and enhance gross profit margins on international Filshie Clip sales.
Realizing new sales of a line of high-pressure process control transducer configurations directly to biopharmaceutical manufacturers to offset the loss of its former largest OEM customer, PendoTECH.
Expected impact: Aims to fully offset the $2.5 million annual revenue headwind from lost OEM and China distributor relationships and establish direct-to-manufacturer biopharma channels.
Focusing on specialized, high-quality clinical devices in smaller, defensible categories (such as neonatal critical care, gynecology, and obstetric emergencies) while maintaining strict operating discipline and reducing manufacturing personnel (e.g., closing the assembly swing shift in Utah) to protect margins against inflation.
Expected impact: Maintains high gross profit margins (consistently near or above 57-60%) and strong cash generation despite flat or slightly declining top-line revenues.